A Mayo Clinic study has found that both metabolic and bariatric surgery and GLP-1 medications improve cardiovascular health in people with obesity, but surgery was associated with significantly greater reductions in long-term cardiovascular risk. The study is a direct comparison of two leading obesity treatments, evaluating how each approach affects the overall risk of cardiovascular disease. The findings are published in Annals of Surgery.
This article was originally published on MedicalXpress.com
